Making labor safer for women and their babies
Press Releases
FOR IMMEDIATE RELEASE - August 24, 2021
MindChild Medical, Inc. Announces Gates Funded UNC LABOR Study Enrolls 6,000th Subject Recorded with Meridian™ Fetal ECG Research Device
The Meridian Fetal Research Device Accurately Extracts Fetal ECG to Enable Analytics on Fetal ECG
Morphology, Heart Rate, Heart Rate Variability and Uterine Activity Using Surface Electrodes
(North Andover, Massachusetts), Mindchild Medical, Inc. announced that the LABOR study recorded its 6,000th subject with MindChild’s Meridian Fetal Research Device. Jay Ward, MindChild Medical’s Executive Vice President stated that “the data shows amazing performance of the Meridian Fetal monitoring technology, producing accurate fetal ECG output under extremely challenging conditions. Excessive maternal movement during the second stage of labor, no pain management coupled with no air conditioning, along with poor electrical power and grounding of these sites, all conspire to make fetal ECG extraction challenging. However, all the sites continue to produce fetal ECG output greater than 85% of the recording time, which is outstanding.”
Total Meridian recording time and data produced from the 6,000 subjects are 17,970 hours and 4,554 gigabytes respectively.
.jpg?crc=3774555551)
In The News
10.2.20 - (North Andover, Massachusetts), MindChild Medical, Inc. today announced it has shipped 24 Meridian M110R Fetal Research Devices and 8,000 electrode patch sets to the UNC LABOR Study’s sites in developing countries of Zambia, Ghana, and India. All of the sites are fully trained on the use of Meridian and actively enrolling subjects...
5.15.20 - (North Andover, Massachusetts), MindChild Medical, Inc. today announced that the LABOR Study selected MindChild’s Meridian Fetal Research Device as the centerpiece of their study due to its unparalleled ability to accurately extract fetal ECG for advanced analytical research. Dr. Jeffrey Stringer, professor of obstetrics & gynecology in the UNC School of Medicine and LABOR Study Principal Investigator, stated that “of the nine companies evaluated, MindChild and their fetal research device is the only one that accurately produces the fetal ECG fidelity required for this study to succeed.”...
MindChild Medical Announces an Exclusive Distribution and Supply Agreement with Henry Schein Medical
4.25.19 - Henry Schein Medical and MindChild Medical Announce an Exclusive Distribution and Supply Agreement for the MERIDIAN M110 Fetal Monitoring System. System Uses Surface Electrodes to Monitor Highly Accurate, Non-Invasive Fetal and Maternal Heart Rate and Uterine Contraction...
MindChild Medical, Inc. Announces Fetal QT Study Publication
MindChild Medical, Inc. Announces FDA Clearance for M110 Monitor
1.16.17 - MindChild has received FDA clearance for the MERIDIAN M110 Fetal Monitoring System. The MERIDIAN M110 adds uterine contraction and maternal heart rate monitoring to its non-invasive fetal heart rate technology using surface electrodes...
MindChild Medical, Inc. Announces ISO 13485 Approval
12.7.15 - MindChild has received ISO 13485:2003 certification for the design, development and manufacturing of its MERIDIAN family of non-invasive Fetal Monitors...
MindChild Medical, Inc. Announces Filing of a 510(k) Application for MERIDIAN™ M110
11.16.15 - MERIDIAN M110 provides continuous non‐invasive fetal and maternal monitoring using surface electrodes that detect fetal ECG, fetal heart rate, maternal heart rate, and uterine contractions...
MindChild Medical Inc. Announces FDA 510(k) Clearance for MERIDIAN M100 Monitor
4.19.15 - The MERIDIAN M100 Fetal Heart Monitor is intended to be compatible with existing fetal monitoring systems, using surface electrodes on the maternal abdomen...
MindChild Medical, Inc. Announces the 1,000th Patient
MindChild Medical, Inc. To Present MERIDIAN™ Fetal Monitor in New Orleans
5.1.13 - See the Non-Invasive Fetal Heart Rate Monitor at the 61st Annual Meeting for the American College of Obstetricians and Gynecologists (ACOG), May 4-8...
MindChild Medical, Inc. to Present MERIDIAN Fetal Monitor in San Francisco
2.4.13 - See MERIDIAN in action, Booth 602, at the 33rd Annual Meeting for the Society for Maternal Fetal Medicine Feb 13-15...
MindChild Medical Inc. Announces Sponsored Research with Oxford University
11.5.12 - Research to develop innovative signal processing software for MERIDIAN Fetal & Maternal Monitor...
MindChild Medical Inc. Announces FDA 510(k) Clearance for MERIDIAN Monitor
9.25.12 - Approved monitor provides continuous non-invasive fetal heart rate from fetal ECG...
MindChild Medical, Inc. Announces Appointment of Thomas Garite, M.D. to the Clinical Advisory Board
6.18.12 - World leader in obstetrics, Dr. Garite to bring tremendous experience to the Clinical Advisory Board...
MindChild Medical, Inc. Announces Results of National Fetal Monitoring Market Survey
6.11.12 - Respondents determine that annual increases in maternal BMI contribute to failures in fetal monitoring nationwide...
MindChild Medical, Inc. Announces Formation of a Clinical Advisory Board
2.22.12 - The MindChild Clinical Advisory Board Will Advise on the Continued Development of the MERIDIAN™ Line of Non-Invasive Fetal Heart Rate Monitors...
MindChild Medical, Inc. Announces Filing of a 510(k) Application for MERIDIAN™
2.6.12 - MERIDIAN is intended to Provide Continuous Non-Invasive Fetal Heart Rate Readings Equivalent to the Gold Standard Fetal Scalp Electrode...
© 2021-2022 Mindchild Medical, Inc. | 1600 Osgood Street | Suite 2017 | North Andover, MA 01845 | info@mindchild.com | 978.566.9880